Skip to main content
Caplight Logo









Rezo Therapeutics

Rezo Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://rezotx.com/

Last Round

Series A

Nov 17, 2022

Total Funding Raised

$78M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rezo Therapeutics is a biotechnology company that pioneers the integrated mapping of disease networks to enhance precision therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryprotein network mappinginteractomeai drug discoverycomputational biologyprotein-protein interactionPPIin silico drug discoverybiotech platformtherapeutic target identificationproteomicsgenomicsai biotechdrug development partnershipvirtual screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rezo Therapeutics Comparables

Compare Rezo Therapeutics with similar companies based on industry and business-model similarity.

Rezo Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pepper Bio
86%
Protai
84%
Terray Therapeutics
81%

Rezo Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 17, 2022

Key People

Founding team and executive leadership

Krystal Fontaine

Chief Operating Officer

Executive Team

Rezo Therapeutics Investors

Notable investors and investment history

Rezo Therapeutics investors
InvestorRounds
Andreessen HorowitzSeries A
SV AngelSeries A
Hawktail ManagementSeries A
Norwest Venture PartnersSeries A
SR OneSeries A
Liquid 2 VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 132% MoM.

  • Aug 12, 2025

    Derek Hicks appointed as the new Chief Executive Officer.

Rezo Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rezo Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rezo Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range45
Year Founded2021
Last FundingNov 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?